Journal article
Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention
J Ramzy, N Andrianopoulos, L Roberts, SJ Duffy, D Clark, AW Teh, AE Ajani, CM Reid, A Brennan, M Freeman
Catheterization and Cardiovascular Interventions | WILEY | Published : 2019
DOI: 10.1002/ccd.28145
Abstract
Objectives: To evaluate the clinical characteristics and outcomes of patients with peripheral vascular disease (PVD) undergoing percutaneous coronary intervention (PCI) in a contemporary setting, and to determine whether use of drug-eluting stents (DESs) improves outcomes. Background: PVD was an independent risk factor for adverse outcomes following PCI in the bare-metal stent (BMS) era. It is not known whether outcomes in these patients have improved with advances in interventional techniques and stent technology, as they have for the general population. Methods: Eighteen thousand three hundred and eighty patients undergoing PCI from an Australian registry between 2005 and 2013 were studied..
View full abstractGrants
Awarded by Abbott Laboratories
Funding Acknowledgements
The Melbourne Interventional Group (MIG) gratefully acknowledges funding from Abbott, AstraZeneca, Medtronic, MSD, Pfizer, Servier, and The Medicines Company. These companies do not have access to data and do not have the right to review manuscripts or abstracts before publication. The MIG Research Group is supported through a National Health & Medical Research Council of Australia Centre of Research Excellence Grant (No. 1111170) and CMR on an NHMRC Research Fellowship (No. 10458620).